Breaking News Instant updates and real-time market news.

CMCSK

Comcast

$0.00

(0.00%)

, CMCSA

Comcast

$44.58

-0.89 (-1.96%)

12:49
11/15/19
11/15
12:49
11/15/19
12:49

Hulu + Live TV price to increase to $54.99 per month from $44.99 per month

Hulu announced that it is letting customers know that the monthly base price of Hulu + Live TV will increase to $54.99, beginning December 18. Hulu currently charges $44.99/month for its Hulu + Live TV tier of service. "The new price better reflects the substantial value of Hulu + Live TV and allows us to continue offering all of the popular live news, sports and entertainment programming included in the plan. Price changes are never easy to stomach, and we know that many people don't watch live television year-round, so we've made it easy for Hulu subscribers to switch back and forth between our plans to best suit their needs...All that said, we realize many Hulu customers want even more choice and control over their live viewing experience, so we're actively exploring ways to provide additional, more tailored live TV options to you in the future. We'll keep you posted on those efforts as they progress," the company stated in a blog post. Hulu is currently owned by Disney (DIS) and Comcast (CMCSA) and the latter has entered into a "put/call" agreement regarding NBCUniversal's 33% ownership interest in Hulu. Reference Link

CMCSK

Comcast

$0.00

(0.00%)

CMCSA

Comcast

$44.58

-0.89 (-1.96%)

DIS

Disney

$145.45

-1.74 (-1.18%)

  • 09

    Dec

CMCSK Comcast
$0.00

(0.00%)

07/29/19
FBCO
07/29/19
NO CHANGE
FBCO
Credit Suisse sees virtually no impact for AT&T, Verizon from Dish near-term
Following the Justice Department's settlement with T-Mobile (TMUS) and Sprint (S), Credit Suisse analyst Douglas Mitchelson notes that for Altice USA (ATUS), the settlement requires mobile virtual network operator contracts to be extended through at least 7 years post closing, which he views as a "significant positive" for Altice. For cable broadly, Dish (DISH) would represent an "intriguing option" for entry into the wireless business longer-term if CEO decided to sell the company, he contends. The analyst would expect that Comcast (CMCSA) and Charter (CHTR) would wait until the point where wireless pricing and valuations are thought to have bottomed. For AT&T (T) and Verizon (VZ), Mitchelson sees virtually no impact from Dish the next few years as the company will be just focused on scaling marketing of its T-Mobile MVNO while building its wireless network. Longer-term, while Dish might be in a position to deflate wireless pricing, AT&T and Verizon should still have superior coverage, network density, backhaul, scale, and quality of service, he adds.
09/25/19
BNCH
09/25/19
INITIATION
Target $64
BNCH
Buy
Comcast initiated with a Buy at Benchmark
Benchmark analyst Matthew Harrigan initiated Comcast with a Buy rating and $64 price target, citing his view that the company is uniquely positioned to benefit from fixed and wireless/mobile broadband growth, direct-to-consumer alternatives to traditional TV bundles and advanced advertising. He sees the potential at Comcast for low teens annual adjusted EPS growth, assuming resumed buyback activity in 2020, Harrigan said.
09/19/19
RSBL
09/19/19
NO CHANGE
Target $134
RSBL
Buy
Roku pullback an 'overreaction' to Comcast's free streaming box, says Rosenblatt
Rosenblatt analyst Mark Zgutowicz said yesterday's weakness in Roku (ROKU) shares was related to news that Comcast (CMSCA) will give its Xfinity Flex streaming box to its broadband only customers for free. However, he thinks the potential impact to Roku looks modest. He thinks Roku has a significant customer acquisition advantage via smart TV sell through, noting that Roku TV sales have represented an estimated 1 of 3 smart TVs sold this year. Zgutowicz maintains a Buy rating and $134 price target on Roku shares, which are down another 1% to $128.26 in pre-market trading.
08/14/19
MACQ
08/14/19
DOWNGRADE
Target $31
MACQ
Neutral
Viacom downgraded to Neutral from Outperform at Macquarie
Macquarie analyst Tim Nollen downgraded Viacom (VIAB) to Neutral from Outperform and keeps a Neutral rating on CBS (CBS) shares after the two companies announced a merger deal with no premium for Viacom following "3 years of on again/off again merger discussions amidst wrenching change in the industry." While he believes the deal's strategic positives outweigh the risks, Nollen said integration might not be easy and that ViacomCBS will still be "small-ish" compared with competitors Comcast (CMCSA) and Disney (DIS). He lowered his price target on Viacom shares to $31 from $37 and cut his price target on CBS shares to $53 from $55.
CMCSA Comcast
$44.58

-0.89 (-1.96%)

10/25/19
GUGG
10/25/19
NO CHANGE
Target $57
GUGG
Negative view of media assets weighing on Comcast sentiment, says Guggenheim
Guggenheim analyst Mike McCormack said Comcast reported a "solid" third quarter with Cable, NBCU, total revenue, broadband net adds and EBITDA topping his expectations. While he expects free cash flow to improve given the combination of lower capex intensity and moving past film and TV working capital headwinds, he believes "sentiment for media assets remains firmly negative," which he thinks is weighing on sentiment for Comcast. He raised his price target on the stock to $57 from $52 and keeps a Buy rating on Comcast shares.
10/25/19
MSCO
10/25/19
NO CHANGE
Target $53
MSCO
Overweight
Morgan Stanley says Comcast results a reminder of 'uniquely attractive position'
Morgan Stanley analyst Benjamin Swinburne said Comcast's Q3 served as a reminder of the company's "uniquely attractive position" with rising returns on invested capital as margins improve and capital intensity falls. While video subscriber losses are increasing, broadband customer growth is accelerating and sustaining this growth is the key to continued share performance, said Swinburne. Although regulatory questions around broadband may come back into focus during the 2020 election process, he also believes the "cumulative impact of years of investment in the network and product set" should not be underestimated, Swinburne added. He keeps an Overweight rating on the stock and bumped up his price target to $53 from $51.
11/14/19
HSBC
11/14/19
DOWNGRADE
HSBC
HSBC downgrades AT&T, Verizon, T-Mobile and Altice USA to Hold
HSBC analyst Sunil Rajgopal downgraded to Hold from Buy shares of AT&T (T), Verizon Communications (VZ), T-Mobile (TMUS) and Altice USA (ATUS). The analyst's only Buy in US Telecoms is now Comcast (CMCSA). Rajgopal keeps Reduce ratings on both Dish (DISH) and Sprint (S). The "evolving content business model" and increasing competition leads the analyst to be more cautious on the pay-TV business and operators with greater exposure to content revenues. Producers are increasingly distributing their content directly to consumers rather than relying on the cable and satellite aggregators, Rajgopal tells investors in a research note. In addition, the entry of a "well-funded" companies like Apple (AAPL) into content production and distribution "with its low sticker price adds to the concerns," contends the analyst. Rajgopal cut his pay-TV subscriber estimates for Comcast, AT&T, Charter and Altice USA to reflect his more cautious stance. The analyst lowered his price target for Altice USA to $28 from $30, raised his price target for AT&T to $42 from $38, raised his price target for Verizon to $65 from $62, and kept an $86 price target on T-Mobile.
11/04/19
SPHN
11/04/19
NO CHANGE
Target $8
SPHN
Equal Weight
Stephens ups WideOpenWest price target to $8, remains concerned on competition
Stephens analyst Kyle Evans said shares of WideOpenWest (WOW) have held up better than he anticipated following the distribution of 27M shares by Avista to limited partners in August and that the stock responded better than he'd expected to the company's Q3 report on Friday. Though he raised his price target on the stock to $8 from $6 after unit economics in the quarter trended positively, Evans keeps an Equal Weight rating on the shares given his concerns about leverage, uncertainty around TV economics and "formidable competition" from the likes of Comcast (CMCSA), Charter (CHTR), Cable One (CABO) and Altice USA (ATUS).
DIS Disney
$145.45

-1.74 (-1.18%)

11/15/19
DBAB
11/15/19
NO CHANGE
Target $139
DBAB
Hold
Disney price target raised to $139 from $132 at Deutsche Bank
Deutsche Bank analyst Bryan Kraft raised his price target for Disney to $139 from $132 saying the company's streaming service is off to an "unprecedented start." However, with an estimated 130M broadband households across the five markets where Disney+ launched this week, the service has already achieved ~8% penetration, Kraft tells investors in a research note. The analyst keeps a Hold rating on Disney shares.
11/14/19
RSBL
11/14/19
NO CHANGE
Target $170
RSBL
Buy
Rosenblatt sees potential for high conversion of Disney+ free trials
Rosenblatt analyst Bernie McTernan said Disney's (DIS) announcement of 10M sign ups in the first roughly 36 hours from the launch of Disney+ don't necessarily equate to paying subscribers, but he sees the potential for high conversion of free trials to paying subscribers based on the company's deal with Verizon (VZ) as well as its pacing of show releases. While he acknowledges that Disney shares appear "optically expensive" based on near-term PE multiples, he thinks this misses the potential value Disney is creating in direct-to-consumer services, McTernan added. McTernan has a Buy rating and $170 price target on Disney shares.
11/14/19
JPMS
11/14/19
NO CHANGE
Target $160
JPMS
Overweight
JPMorgan ups Disney target to $160 on positive early streaming surprise
JPMorgan analyst Alexia Quadrani raised her price target for Disney to $160 from $150 after the company announced yesterday that Disney+ has reached over 10M subscribers after its launch yesterday in the U.S., Canada, and Netherlands. Disney closed Wednesday up 7%, or $10.14, to $148.72. On November 19, Disney+ will launch in Australia, New Zealand, and Puerto Rico, and will launch in Western Europe on March 31, 2020, Quadrani tells investors in a research note. The analyst is positive on the "early surprise announcement of strong subscriber growth." The announcement surpassed her expectations for 5M subscribers in Q1. Quadrani now expects 15M subscribers in the quarter and bumped up her full year expectations from 15M to 25M. She has "strong conviction" that Disney shares are well positioned to continue to outperform. The analyst keeps an Overweight rating on the stock.
11/13/19
FBCO
11/13/19
NO CHANGE
Target $163
FBCO
Outperform
Disney price target raised to $163 from $150 at Credit Suisse

TODAY'S FREE FLY STORIES

04:00
12/09/19
12/09
04:00
12/09/19
04:00
General news
FX Action: USD-CAD has consolidated around 1.3250 »

FX Action: USD-CAD has…

03:20
12/09/19
12/09
03:20
12/09/19
03:20
General news
FX Update: The pound rallied to new highs »

FX Update: The pound…

03:05
12/09/19
12/09
03:05
12/09/19
03:05
General news
Asian Market Update: »

Asian Market Update:…

03:05
12/09/19
12/09
03:05
12/09/19
03:05
General news
FOMC Forecast revisions »

FOMC Forecast revisions,…

03:05
12/09/19
12/09
03:05
12/09/19
03:05
General news
With or without a "phase one" deal »

With or without a…

PLMR

Palomar

20:27
12/08/19
12/08
20:27
12/08/19
20:27
Recommendations
Palomar analyst commentary at Keefe Bruyette »

Palomar price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 11

    Dec

ASAZY

Assa Abloy

$0.00

(0.00%)

20:23
12/08/19
12/08
20:23
12/08/19
20:23
Downgrade
Assa Abloy rating change at JPMorgan »

Assa Abloy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RXEEY

Rexel

$0.00

(0.00%)

20:23
12/08/19
12/08
20:23
12/08/19
20:23
Upgrade
Rexel rating change at JPMorgan »

Rexel upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TATYY

Tate & Lyle

$0.00

(0.00%)

20:22
12/08/19
12/08
20:22
12/08/19
20:22
Upgrade
Tate & Lyle rating change at Jefferies »

Tate & Lyle upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AUO

AU Optronics

$0.00

(0.00%)

20:20
12/08/19
12/08
20:20
12/08/19
20:20
Upgrade
AU Optronics rating change at Morgan Stanley »

AU Optronics upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPL

LG Display

$6.22

0.115 (1.89%)

20:17
12/08/19
12/08
20:17
12/08/19
20:17
Upgrade
LG Display rating change at Morgan Stanley »

LG Display upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

ETNB

89bio

$28.38

0.86 (3.13%)

20:16
12/08/19
12/08
20:16
12/08/19
20:16
Initiation
89bio initiated at Oppenheimer »

89bio initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANIOY

Acerinox

$0.00

(0.00%)

20:15
12/08/19
12/08
20:15
12/08/19
20:15
Upgrade
Acerinox rating change at Jefferies »

Acerinox upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BPMC

Blueprint Medicines

$78.50

3.92 (5.26%)

20:15
12/08/19
12/08
20:15
12/08/19
20:15
Conference/Events
Blueprint Medicines to hold an anlayst and investor event »

Management reviews the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

TLSNY

Telia

$0.00

(0.00%)

20:14
12/08/19
12/08
20:14
12/08/19
20:14
Downgrade
Telia rating change at Jefferies »

Telia downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARWR

Arrowhead

$67.25

1.705 (2.60%)

20:13
12/08/19
12/08
20:13
12/08/19
20:13
Recommendations
Arrowhead analyst commentary at Piper Jaffray »

Arrowhead price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARGX

Argenx

$147.31

-2.56 (-1.71%)

20:08
12/08/19
12/08
20:08
12/08/19
20:08
Recommendations
Argenx analyst commentary at Stifel »

Argenx price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

STC

Stewart

$43.16

0.28 (0.65%)

19:56
12/08/19
12/08
19:56
12/08/19
19:56
Downgrade
Stewart rating change at Keefe Bruyette »

Stewart downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FAF

First American

$63.05

(0.00%)

19:55
12/08/19
12/08
19:55
12/08/19
19:55
Downgrade
First American rating change at Keefe Bruyette »

First American downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

PFSI

PennyMac Financial

$33.91

0.12 (0.36%)

19:54
12/08/19
12/08
19:54
12/08/19
19:54
Downgrade
PennyMac Financial rating change at Keefe Bruyette »

PennyMac downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGIO

Agios Pharmaceuticals

$40.93

0.81 (2.02%)

18:40
12/08/19
12/08
18:40
12/08/19
18:40
Recommendations
Agios Pharmaceuticals analyst commentary at Piper Jaffray »

Agios' initial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 13

    Dec

BPMC

Blueprint Medicines

$78.50

3.92 (5.26%)

18:34
12/08/19
12/08
18:34
12/08/19
18:34
Recommendations
Blueprint Medicines analyst commentary at Piper Jaffray »

Piper says 'jury…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

FATE

Fate Therapeutics

$13.64

0.07 (0.52%)

18:29
12/08/19
12/08
18:29
12/08/19
18:29
Recommendations
Fate Therapeutics analyst commentary at Piper Jaffray »

FT500 data validates Fate…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCKT

Rocket Pharmaceuticals

$22.37

2.61 (13.21%)

18:05
12/08/19
12/08
18:05
12/08/19
18:05
Hot Stocks
Rocket says Phase 1 trial establishes feasibility of commercial Process B for FA »

Rocket Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

ARGX

Argenx

$147.31

-2.56 (-1.71%)

, JNJ

Johnson & Johnson

$140.36

0.79 (0.57%)

18:03
12/08/19
12/08
18:03
12/08/19
18:03
Recommendations
Argenx, Johnson & Johnson analyst commentary at Piper Jaffray »

Argenx data on…

ARGX

Argenx

$147.31

-2.56 (-1.71%)

JNJ

Johnson & Johnson

$140.36

0.79 (0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 09

    Dec

  • 16

    Dec

  • 21

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.